References
DBP Diastolic Blood Pressure, liver steatosis
LIVER STEATOSIS, BLOOD, ELEVATED TRIGLYCERIDES, ADIPOSITY, ELEVATED BLOOD PRESSURE
CONSORT patient flow diagram.Baseline characteristics of participants by study group sequence (first intervention labelled).CaucasianSouth AsianEast AsianHispanicMalesFemales†: Based on presence of 3/5 diagnostic criteria—central adiposity, elevated triglycerides, reduced high density lipoprotein, elevated blood pressure, and elevated plasma glucosePaired analysis of outcome change by intervention. CAP: Controlled Attenuation Parameter, SBP: Systolic Blood Pressure, DBP Diastolic Blood Pressure, BMI: Body Mass Index, ALT: Alanine Transaminase, LDL: Low-Density Lipoprotein, HDL: High-Density Lipoprotein.Within-group changes over the 12-week intervention period. CAP: Controlled Attenuation Parameter, SBP: Systolic Blood Pressure, DBP Diastolic Blood Pressure, BMI: Body Mass Index, ALT: Alanine Transaminase, LDL: Low-Density Lipoprotein, HDL: High-Density Lipoprotein.Outcome change between interventions in participants with significant baseline liver steatosis (CAP ≥ 268 dB/m). CAP: Controlled Attenuation Parameter; ALT: Alanine Transaminase.Satiety and physical activity.